Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 11 04:00PM ET
1.62
Dollar change
-0.03
Percentage change
-1.82
%
IndexRUT P/E- EPS (ttm)-0.19 Insider Own54.82% Shs Outstand682.48M Perf Week3.85%
Market Cap1.11B Forward P/E- EPS next Y-0.29 Insider Trans0.54% Shs Float308.38M Perf Month10.20%
Income-133.76M PEG- EPS next Q-0.09 Inst Own30.03% Short Float28.51% Perf Quarter11.72%
Sales711.40M P/S1.55 EPS this Y28.00% Inst Trans3.14% Short Ratio22.63 Perf Half Y8.00%
Book/sh2.06 P/B0.79 EPS next Y-62.96% ROA-6.20% Short Interest87.92M Perf Year58.82%
Cash/sh0.60 P/C2.72 EPS next 5Y20.98% ROE-9.39% 52W Range0.86 - 1.76 Perf YTD10.20%
Dividend Est.- P/FCF- EPS past 5Y1.56% ROI-7.09% 52W High-7.95% Beta1.73
Dividend TTM- Quick Ratio2.69 Sales past 5Y6.34% Gross Margin13.32% 52W Low88.35% ATR (14)0.06
Dividend Ex-Date- Current Ratio2.97 EPS Y/Y TTM33.72% Oper. Margin-43.51% RSI (14)62.51 Volatility3.63% 3.51%
Employees3930 Debt/Eq0.37 Sales Y/Y TTM-17.95% Profit Margin-18.80% Recom1.00 Target Price3.96
Option/ShortYes / Yes LT Debt/Eq0.35 EPS Q/Q122.15% Payout- Rel Volume0.50 Prev Close1.65
Sales Surprise-4.37% EPS Surprise132.15% Sales Q/Q-2.78% EarningsNov 07 AMC Avg Volume3.88M Price1.62
SMA206.23% SMA505.76% SMA20010.88% Trades Volume1,942,918 Change-1.82%
Date Action Analyst Rating Change Price Target Change
Jun-29-23Upgrade Barrington Research Mkt Perform → Outperform $2
Dec-15-22Initiated H.C. Wainwright Buy $3
Jan-24-22Downgrade Barrington Research Outperform → Mkt Perform
Jun-21-21Initiated Ladenburg Thalmann Buy $7
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Jan-27-25 08:00AM
Jan-20-25 10:02PM
Jan-09-25 11:45AM
Jan-07-25 08:00AM
Dec-11-24 02:08AM
08:00AM Loading…
Dec-10-24 08:00AM
Nov-29-24 02:43PM
Nov-20-24 08:00AM
Nov-18-24 08:00AM
Nov-15-24 08:34PM
Nov-14-24 06:00AM
Nov-08-24 04:05PM
04:01AM
Nov-07-24 10:15PM
08:00PM
06:40PM Loading…
06:40PM
05:35PM
04:05PM
08:00AM
Oct-29-24 04:05PM
Oct-07-24 08:00AM
08:00AM
Sep-25-24 08:30AM
Sep-23-24 08:00AM
Sep-16-24 07:30AM
Aug-09-24 04:05PM
Aug-08-24 12:14PM
12:15AM
Aug-07-24 08:00PM
06:59PM
04:06PM Loading…
04:06PM
Aug-01-24 04:05PM
Jul-18-24 08:00AM
Jul-17-24 04:14PM
Jul-08-24 06:54PM
12:30PM
Jul-02-24 08:00AM
Jun-06-24 11:31AM
May-31-24 10:48AM
10:00AM
May-12-24 03:24PM
May-09-24 09:18AM
May-08-24 11:47AM
06:56AM
03:44AM
May-07-24 09:15PM
08:30PM
06:09PM
05:30PM
04:38PM
04:05PM
May-03-24 08:00AM
Apr-01-24 01:01PM
Mar-28-24 11:08PM
08:00AM
Mar-25-24 09:57AM
Mar-20-24 08:00AM
Mar-05-24 08:52AM
Feb-29-24 08:31AM
Feb-28-24 09:31AM
09:02AM
06:18AM
Feb-27-24 09:00PM
07:30PM
06:10PM
05:08PM
04:43PM
04:05PM
Feb-26-24 09:16AM
Feb-22-24 04:05PM
Feb-08-24 01:48PM
Feb-05-24 08:09AM
Jan-22-24 11:48AM
Jan-09-24 04:05PM
Jan-08-24 08:00AM
Jan-04-24 11:31PM
Jan-03-24 05:05PM
Dec-07-23 10:20AM
Dec-06-23 11:30AM
Nov-28-23 07:00AM
Nov-07-23 10:36AM
10:29AM
09:19AM
06:45AM
01:00AM
Nov-06-23 07:30PM
05:30PM
05:01PM
04:05PM
Nov-02-23 10:00AM
Oct-31-23 08:00AM
Oct-25-23 04:25PM
Oct-12-23 10:50AM
Oct-06-23 12:03PM
Sep-29-23 01:03PM
Sep-28-23 07:36PM
04:08PM
Sep-13-23 01:18PM
Sep-12-23 08:30AM
Aug-28-23 11:56AM
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanJan 28 '25Buy1.4747,53770,060213,234,014Jan 28 05:40 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17 '25Buy1.47150,000220,425213,186,477Jan 17 05:06 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 15 '25Buy1.48500,000740,850213,036,477Jan 15 05:18 PM
FROST PHILLIP MD ET ALCEO & ChairmanDec 13 '24Buy1.59125,000199,375212,536,477Dec 13 05:04 PM
FROST PHILLIP MD ET ALCEO & ChairmanDec 11 '24Buy1.56500,000781,050212,411,477Dec 11 05:21 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 29 '24Buy1.53199,072305,376211,911,477Nov 29 03:20 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 22 '24Buy1.59100,000159,000211,712,405Nov 22 05:17 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 14 '24Buy1.62100,000161,980211,612,405Nov 14 05:51 PM
FROST PHILLIP MD ET ALCEO & ChairmanNov 08 '24Buy1.50280,183421,535211,512,405Nov 08 05:40 PM
OPKO HEALTH, INC.10% OwnerSep 17 '24Proposed Sale40.8813,404547,956Sep 20 02:56 PM
OPKO HEALTH, INC.10% OwnerAug 19 '24Sale34.4950,0001,724,5202,646,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 16 '24Sale34.3050,0001,714,8502,696,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 15 '24Sale33.0839,8241,317,5052,746,972Aug 19 05:23 PM
OPKO HEALTH, INC.10% OwnerAug 12 '24Sale33.9559,7872,029,8112,811,783Aug 14 04:50 PM
OPKO HEALTH, INC.10% OwnerAug 13 '24Sale34.7624,987868,5032,786,796Aug 14 04:50 PM
OPKO HEALTH, INC.10% OwnerAug 08 '24Sale31.82100,0003,182,3802,871,570Aug 08 05:39 PM
OPKO HEALTH, INC.10% OwnerAug 06 '24Sale29.3512,994381,4272,971,570Aug 08 05:39 PM
OPKO HEALTH, INC.10% OwnerJul 31 '24Sale33.5088,8392,976,3462,984,564Aug 02 04:21 PM
OPKO HEALTH, INC.10% OwnerJul 29 '24Sale33.8650,0001,692,8903,073,403Jul 31 05:03 PM
OPKO HEALTH, INC.10% OwnerJul 24 '24Sale33.7275,0002,529,1053,183,403Jul 26 07:49 PM
OPKO HEALTH, INC.10% OwnerJul 26 '24Sale33.8560,0002,031,2583,123,403Jul 26 07:49 PM
OPKO HEALTH, INC.10% OwnerJul 23 '24Sale33.4675,0002,509,2453,258,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 22 '24Sale32.6150,0001,630,4403,333,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 19 '24Sale32.2925,000807,2503,383,403Jul 23 05:16 PM
OPKO HEALTH, INC.10% OwnerJul 17 '24Sale32.9325,000823,1883,408,403Jul 19 06:46 PM
OPKO HEALTH, INC.10% OwnerJul 05 '24Sale28.2436,1181,020,0163,433,403Jul 09 04:07 PM
OPKO HEALTH, INC.10% OwnerJul 01 '24Sale26.6350,0001,331,7003,508,603Jul 03 04:56 PM
OPKO HEALTH, INC.10% OwnerJul 02 '24Sale29.1225,000728,0953,483,603Jul 03 04:56 PM
OPKO HEALTH, INC.10% OwnerJul 03 '24Sale28.2314,082397,4913,469,521Jul 03 04:56 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 23 '24Buy1.27100,000126,937211,232,222May 23 08:04 PM
FROST PHILLIP MD ET ALCEO & ChairmanMay 17 '24Buy1.29163,997211,195211,132,222May 17 05:31 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 18 '24Buy0.87500,000437,100210,968,225Mar 18 04:45 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 14 '24Buy0.89500,000444,300210,468,225Mar 14 05:00 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 13 '24Buy0.93500,000463,750209,968,225Mar 13 04:44 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 12 '24Buy0.93600,000559,380209,468,225Mar 12 05:27 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28 '24Buy0.99500,000496,150208,868,225Feb 28 05:31 PM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 21 '24Buy0.991,000,000991,700208,368,225Feb 21 05:10 PM
Last Close
Feb 11 04:00PM ET
2.51
Dollar change
+0.21
Percentage change
9.13
%
BCDA BioCardia Inc daily Stock Chart
Index- P/E- EPS (ttm)-4.16 Insider Own17.17% Shs Outstand4.52M Perf Week-2.33%
Market Cap11.50M Forward P/E- EPS next Y-1.31 Insider Trans0.09% Shs Float3.80M Perf Month18.04%
Income-7.72M PEG- EPS next Q-0.62 Inst Own2.76% Short Float0.84% Perf Quarter6.10%
Sales0.07M P/S164.32 EPS this Y62.30% Inst Trans16.27% Short Ratio0.65 Perf Half Y-6.34%
Book/sh0.61 P/B4.12 EPS next Y57.88% ROA-154.22% Short Interest0.03M Perf Year-58.39%
Cash/sh1.08 P/C2.33 EPS next 5Y44.44% ROE-737.89% 52W Range1.62 - 8.85 Perf YTD15.14%
Dividend Est.- P/FCF- EPS past 5Y30.13% ROI-225.33% 52W High-71.64% Beta1.26
Dividend TTM- Quick Ratio1.78 Sales past 5Y122.23% Gross Margin-498.59% 52W Low54.46% ATR (14)0.24
Dividend Ex-Date- Current Ratio1.78 EPS Y/Y TTM55.71% Oper. Margin-10935.21% RSI (14)57.91 Volatility11.44% 10.83%
Employees20 Debt/Eq0.38 Sales Y/Y TTM-87.54% Profit Margin-10876.06% Recom1.00 Target Price15.50
Option/ShortNo / Yes LT Debt/Eq0.24 EPS Q/Q65.61% Payout- Rel Volume1.88 Prev Close2.30
Sales Surprise-100.00% EPS Surprise48.74% Sales Q/Q-100.00% EarningsNov 13 AMC Avg Volume49.25K Price2.51
SMA208.64% SMA5012.28% SMA200-17.52% Trades Volume92,640 Change9.13%
Date Action Analyst Rating Change Price Target Change
Apr-16-21Downgrade Dawson James Buy → Neutral
Jan-31-25 07:16AM
Jan-27-25 09:15AM
Dec-17-24 07:00AM
Dec-04-24 08:30AM
Nov-14-24 02:13AM
04:05PM Loading…
Nov-13-24 04:05PM
Nov-06-24 07:00AM
Oct-28-24 09:00AM
Oct-09-24 06:19PM
Sep-18-24 08:30AM
Sep-09-24 04:05PM
Aug-30-24 08:00AM
Aug-29-24 08:30AM
Aug-21-24 07:00AM
Aug-13-24 04:30PM
07:00AM Loading…
Aug-07-24 07:00AM
Jul-30-24 07:00AM
Jul-25-24 07:00AM
Jul-17-24 07:00AM
Jul-08-24 07:00AM
Jun-10-24 07:32AM
Jun-07-24 07:00AM
Jun-04-24 07:52AM
May-21-24 05:00PM
May-15-24 03:08AM
May-14-24 08:56PM
04:02PM
May-09-24 07:00AM
May-01-24 07:00AM
Apr-25-24 09:00AM
05:41PM Loading…
Apr-02-24 05:41PM
Apr-01-24 02:30PM
Mar-28-24 05:58AM
Mar-27-24 08:53PM
04:00PM
Mar-20-24 07:00AM
Mar-13-24 07:00AM
Mar-12-24 07:00AM
Mar-04-24 09:27AM
08:00AM
Feb-08-24 07:00AM
Jan-31-24 07:00AM
Jan-03-24 07:00AM
Dec-19-23 07:00AM
Dec-18-23 07:16AM
Nov-29-23 07:00AM
Nov-16-23 12:56PM
Nov-15-23 11:04AM
Nov-14-23 07:15AM
Nov-09-23 12:48PM
06:59AM
Nov-08-23 05:52PM
05:50PM
04:11PM
Nov-01-23 05:04PM
Oct-12-23 11:08AM
Oct-11-23 06:00AM
Sep-06-23 10:31AM
07:15AM
Sep-05-23 07:15AM
Aug-11-23 09:29AM
Aug-09-23 06:05PM
04:05PM
Aug-02-23 07:00AM
Jul-24-23 07:00AM
Jul-10-23 08:11AM
Jul-05-23 07:00AM
Jun-20-23 05:14PM
Jun-08-23 07:00AM
May-28-23 08:08AM
May-23-23 07:00AM
May-12-23 06:06AM
May-10-23 05:45PM
04:05PM
May-09-23 07:00AM
May-03-23 08:00PM
Apr-28-23 07:00AM
Apr-04-23 07:00AM
Apr-01-23 12:47PM
Mar-31-23 06:05AM
Mar-29-23 08:15AM
Mar-16-23 07:00AM
Mar-06-23 01:06PM
07:00AM
Feb-01-23 06:30AM
Jan-31-23 05:39AM
Dec-22-22 07:00AM
Dec-21-22 05:07AM
Dec-15-22 07:00AM
Dec-06-22 07:00AM
Nov-09-22 05:35PM
04:05PM
12:00PM
Nov-02-22 05:31PM
Oct-03-22 01:33PM
07:00AM
Sep-14-22 07:00AM
Sep-09-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 11:03AM
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOFeb 07 '25Buy2.486001,488107,920Feb 11 05:42 PM
Altman PeterPresident and CEOJan 29 '25Buy2.405001,200107,081Jan 30 08:36 PM
Altman PeterPresident and CEOJan 30 '25Buy2.38239569107,320Jan 30 08:36 PM
Altman PeterPresident and CEODec 23 '24Buy2.061,0002,060106,581Dec 26 02:30 PM
GILLIS EDWARD MSenior Vice President, DevicesDec 20 '24Sale2.003,2576,5148,968Dec 26 02:30 PM
GILLIS EDWARD MOfficerDec 17 '24Proposed Sale2.033,2576,611Dec 17 11:50 AM
Altman PeterPresident and CEODec 05 '24Buy2.22250555105,581Dec 09 05:04 PM
Altman PeterPresident and CEONov 15 '24Buy1.871,3502,524105,331Nov 19 08:00 AM
Altman PeterPresident and CEOJul 01 '24Buy3.0530091539,745Jul 02 04:12 PM
Altman PeterPresident and CEOJun 28 '24Buy2.9920059839,445Jul 02 04:12 PM
Altman PeterPresident and CEOJun 21 '24Buy3.295001,64539,245Jun 24 08:46 AM
Altman PeterPresident and CEOJun 14 '24Buy3.525001,76038,745Jun 17 07:00 AM
Altman PeterPresident and CEOJun 10 '24Buy3.361,0003,36038,245Jun 12 07:00 AM
Altman PeterPresident and CEOApr 19 '24Buy0.372,7501,013558,697Apr 19 05:38 PM
Altman PeterPresident and CEOMar 28 '24Buy0.39500195555,947Mar 28 07:33 PM
Altman PeterPresident and CEOFeb 13 '24Buy0.46108,10850,000555,447Feb 15 07:00 AM
Last Close
Feb 11 04:00PM ET
2.97
Dollar change
+0.05
Percentage change
1.88
%
FLNT Fluent Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.82 Insider Own54.23% Shs Outstand16.88M Perf Week5.50%
Market Cap57.59M Forward P/E- EPS next Y-0.53 Insider Trans-0.01% Shs Float8.86M Perf Month13.12%
Income-27.75M PEG- EPS next Q-0.23 Inst Own29.03% Short Float0.33% Perf Quarter1.19%
Sales261.98M P/S0.22 EPS this Y-142.59% Inst Trans84.06% Short Ratio1.59 Perf Half Y5.50%
Book/sh1.18 P/B2.51 EPS next Y59.92% ROA-26.67% Short Interest0.03M Perf Year-4.08%
Cash/sh0.34 P/C8.74 EPS next 5Y- ROE-100.04% 52W Range2.31 - 4.30 Perf YTD18.06%
Dividend Est.- P/FCF- EPS past 5Y- ROI-108.85% 52W High-30.80% Beta2.30
Dividend TTM- Quick Ratio0.94 Sales past 5Y2.15% Gross Margin21.93% 52W Low28.82% ATR (14)0.15
Dividend Ex-Date- Current Ratio0.94 EPS Y/Y TTM80.69% Oper. Margin-5.33% RSI (14)58.06 Volatility6.39% 4.77%
Employees277 Debt/Eq2.02 Sales Y/Y TTM-15.57% Profit Margin-10.59% Recom3.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.28 EPS Q/Q80.17% Payout- Rel Volume0.30 Prev Close2.92
Sales Surprise-5.99% EPS Surprise-193.33% Sales Q/Q-2.60% EarningsNov 14 AMC Avg Volume18.15K Price2.97
SMA203.68% SMA507.19% SMA200-4.45% Trades Volume5,451 Change1.88%
Date Action Analyst Rating Change Price Target Change
May-10-22Upgrade Barrington Research Mkt Perform → Outperform $2.50
Mar-17-21Downgrade Barrington Research Outperform → Mkt Perform
Nov-02-20Upgrade Barrington Research Mkt Perform → Outperform $4.50
Aug-26-20Initiated Canaccord Genuity Buy $5
Nov-12-19Downgrade Barrington Research Outperform → Mkt Perform
May-09-19Upgrade ROTH Capital Neutral → Buy $5.50 → $8.50
Feb-05-25 08:30AM
Jan-27-25 12:00PM
Jan-17-25 03:34PM
Jan-07-25 08:30AM
Dec-06-24 03:17PM
05:58PM Loading…
Nov-29-24 05:58PM
Nov-19-24 04:00PM
Nov-15-24 01:04PM
02:15AM
Nov-14-24 05:12PM
04:15PM
Nov-13-24 02:30PM
Sep-10-24 10:00AM
Sep-06-24 08:30AM
Aug-22-24 09:40AM
08:11AM Loading…
Aug-20-24 08:11AM
Aug-19-24 05:10PM
04:00PM
Aug-15-24 10:00AM
Jul-12-24 08:30AM
Jun-28-24 08:30AM
May-28-24 09:40AM
May-16-24 11:39AM
08:16AM
07:34AM
03:07AM
May-15-24 08:52PM
04:45PM
04:15PM
May-09-24 01:19PM
07:00AM Loading…
May-02-24 07:00AM
Apr-10-24 08:00AM
Apr-03-24 09:00AM
06:44AM
Apr-02-24 05:32PM
Apr-01-24 10:48PM
Mar-21-24 09:00AM
Feb-29-24 02:25PM
12:22PM
Feb-27-24 09:00AM
Jan-25-24 08:30AM
Nov-15-23 09:55AM
Nov-14-23 05:11PM
04:54PM
04:15PM
Nov-03-23 03:00PM
Aug-22-23 08:30AM
Aug-15-23 12:04PM
06:05AM
Aug-14-23 04:30PM
Aug-09-23 09:09PM
Aug-08-23 08:30AM
Aug-02-23 08:30AM
Aug-01-23 03:30PM
Jul-27-23 08:30AM
Jul-10-23 10:14AM
Jun-13-23 08:42AM
May-17-23 06:15AM
May-16-23 08:01AM
May-15-23 04:15PM
May-12-23 02:10PM
May-11-23 09:40AM
May-02-23 05:50PM
08:30AM
May-01-23 09:00AM
Apr-26-23 05:50PM
Apr-20-23 05:50PM
Apr-18-23 10:02AM
09:00AM
Apr-07-23 09:35AM
Apr-06-23 08:30AM
Apr-05-23 09:40AM
Mar-20-23 09:40AM
05:33AM
Mar-18-23 03:12AM
Mar-17-23 06:16AM
Mar-16-23 05:53AM
Mar-15-23 04:15PM
Feb-27-23 09:00AM
Feb-08-23 09:40AM
Jan-25-23 05:50AM
Jan-20-23 09:40AM
Jan-15-23 03:10PM
Dec-22-22 07:38AM
Nov-07-22 04:01PM
Oct-26-22 08:30AM
Oct-19-22 07:53AM
Oct-17-22 08:30AM
Oct-11-22 08:30AM
Oct-05-22 08:30AM
Sep-14-22 06:30AM
Sep-13-22 08:30AM
Aug-18-22 06:16AM
Aug-09-22 08:00PM
05:55PM
04:30PM
04:01PM
Aug-08-22 11:30AM
Aug-04-22 05:51PM
Jul-22-22 08:50AM
Fluent, Inc. engages in the provision of digital marketing services. It operates through the Fluent and All Other segments. The Fluent segment includes delivering data and performance-based marketing executions. The All Other segment represents the operation results of AdParlor, LLC, a digital advertising solution for social media buying. The company was founded by Ryan Schulke and Matthew Conlin in 2001 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patrick Donald HuntleyChief Executive OfficerSep 12 '24Sale2.6720,25054,068329,063Dec 16 04:16 PM
GLOBAL VALUE INVESTMENT CORP.10% OwnerDec 05 '24Buy2.6914,33738,5543,056,403Dec 06 04:30 PM
GLOBAL VALUE INVESTMENT CORP.10% OwnerDec 04 '24Buy2.745,04513,8263,042,066Dec 06 04:30 PM
Patrick Donald HuntleyChief Executive OfficerJul 17 '24Option Exercise0.0029,55115349,313Jul 17 06:20 PM
Conlin MatthewChief Customer OfficerJul 17 '24Option Exercise0.00487,5892441,601,164Jul 17 05:00 PM
Conlin MatthewChief Customer OfficerJul 17 '24Option Exercise0.0073,87737125,039Jul 17 05:00 PM
Schulke RyanChief Strategy OfficerJul 09 '24Option Exercise0.001,743,4998722,941,164Jul 11 12:40 PM
Schulke RyanChief Strategy OfficerJun 14 '24Buy3.423,00010,246103,027Jun 18 04:43 PM
Schulke RyanChief Strategy OfficerMar 14 '24Buy0.5321,00011,128600,159Mar 14 05:57 PM
Schulke RyanChief Strategy OfficerMar 13 '24Buy0.5310,0005,299579,159Mar 14 05:57 PM
Perfit Ryan MacNabInterim CFOMar 11 '24Buy0.5810,0005,78745,596Mar 12 06:26 PM
Perfit Ryan MacNabInterim CFOMar 08 '24Buy0.5759634035,596Mar 12 06:26 PM
Schulke RyanChief Strategy OfficerMar 12 '24Buy0.5920,00011,858569,159Mar 12 06:17 PM
Schulke RyanChief Strategy OfficerMar 08 '24Buy0.6210,0006,187549,159Mar 11 09:43 PM
Schulke RyanChief Strategy OfficerMar 07 '24Buy0.5910,0005,900539,159Mar 07 05:43 PM
Perfit Ryan MacNabInterim CFOMar 04 '24Buy0.5910,0005,90035,000Mar 06 06:25 PM
Schulke RyanChief Strategy OfficerMar 04 '24Buy0.6010,0005,973509,159Mar 06 06:25 PM
Schulke RyanChief Strategy OfficerMar 05 '24Buy0.5310,0005,336519,159Mar 06 06:25 PM
Schulke RyanChief Strategy OfficerMar 06 '24Buy0.5210,0005,201529,159Mar 06 06:25 PM
Last Close
Feb 11 04:00PM ET
2.22
Dollar change
-0.06
Percentage change
-2.63
%
COCP Cocrystal Pharma Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.84 Insider Own31.67% Shs Outstand10.17M Perf Week12.69%
Market Cap22.59M Forward P/E- EPS next Y-2.16 Insider Trans0.00% Shs Float6.95M Perf Month0.45%
Income-18.70M PEG- EPS next Q-0.53 Inst Own7.07% Short Float0.27% Perf Quarter30.59%
Sales0.00M P/S- EPS this Y-3.21% Inst Trans6.68% Short Ratio0.41 Perf Half Y23.54%
Book/sh1.25 P/B1.78 EPS next Y-11.92% ROA-76.57% Short Interest0.02M Perf Year48.00%
Cash/sh1.29 P/C1.72 EPS next 5Y-11.32% ROE-86.20% 52W Range1.33 - 3.26 Perf YTD9.90%
Dividend Est.- P/FCF- EPS past 5Y-1.25% ROI-130.92% 52W High-31.90% Beta2.33
Dividend TTM- Quick Ratio7.32 Sales past 5Y-42.33% Gross Margin- 52W Low67.55% ATR (14)0.20
Dividend Ex-Date- Current Ratio7.32 EPS Y/Y TTM8.73% Oper. Margin- RSI (14)55.52 Volatility10.22% 8.53%
Employees12 Debt/Eq0.15 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.33
Option/ShortNo / Yes LT Debt/Eq0.12 EPS Q/Q-18.33% Payout- Rel Volume1.14 Prev Close2.28
Sales Surprise- EPS Surprise14.04% Sales Q/Q- EarningsNov 13 BMO Avg Volume45.02K Price2.22
SMA2010.60% SMA504.53% SMA2009.79% Trades Volume51,309 Change-2.63%
Date Action Analyst Rating Change Price Target Change
Jul-08-20Initiated H.C. Wainwright Buy $5
Jan-08-25 08:00AM
Jan-02-25 06:34AM
Dec-31-24 02:03PM
08:00AM
Nov-13-24 08:00AM
08:00AM Loading…
Oct-31-24 08:00AM
Sep-26-24 08:00AM
Aug-19-24 04:05PM
Aug-15-24 03:00PM
Aug-14-24 08:00AM
Jul-18-24 08:00AM
Jun-20-24 08:00AM
Jun-07-24 09:55AM
May-13-24 01:53PM
08:00AM
08:00AM Loading…
May-01-24 08:00AM
Mar-28-24 01:53PM
08:00AM
Mar-19-24 08:00AM
Mar-05-24 08:30AM
Jan-04-24 08:00AM
Dec-06-23 08:00AM
Nov-29-23 08:00AM
Nov-27-23 08:00AM
Nov-13-23 08:00AM
Nov-09-23 08:00AM
Oct-31-23 08:00AM
Oct-02-23 12:14PM
Sep-28-23 08:00AM
Sep-05-23 08:00AM
09:11AM Loading…
Aug-16-23 09:11AM
Aug-14-23 08:00AM
Aug-08-23 08:00AM
May-31-23 08:00AM
May-17-23 09:26AM
May-15-23 08:00AM
May-04-23 04:05PM
Apr-24-23 08:00AM
Apr-18-23 08:00AM
Apr-10-23 08:30AM
Mar-31-23 10:05AM
Mar-29-23 08:00AM
Mar-22-23 01:03PM
08:00AM
Jan-26-23 08:00AM
Jan-23-23 09:00AM
Dec-19-22 08:00AM
Dec-01-22 04:05PM
Nov-17-22 01:38PM
08:00AM
Nov-15-22 11:19AM
Nov-14-22 08:00AM
Nov-02-22 08:00AM
Nov-01-22 04:05PM
Oct-26-22 08:00AM
Oct-19-22 08:00AM
Oct-13-22 08:00AM
Oct-11-22 11:51AM
08:00AM
Oct-05-22 08:00AM
Oct-03-22 04:05PM
Sep-06-22 10:05AM
08:00AM
Aug-19-22 08:10AM
Aug-15-22 08:00AM
Aug-08-22 08:00AM
Aug-03-22 09:00AM
Jul-14-22 08:00AM
Jun-01-22 08:00AM
May-18-22 08:00AM
May-12-22 08:12AM
May-11-22 08:00AM
Apr-21-22 08:00AM
Apr-19-22 08:00AM
Apr-14-22 08:00AM
Apr-12-22 11:01AM
08:00AM
Apr-06-22 10:15AM
Mar-30-22 02:57PM
Mar-25-22 07:30AM
Mar-23-22 04:05PM
Mar-22-22 08:00AM
Mar-10-22 08:00AM
Mar-03-22 08:00AM
Feb-24-22 08:10AM
Jan-27-22 12:22PM
08:00AM
Jan-11-22 07:00AM
Jan-10-22 04:10PM
Jan-06-22 08:00AM
Jan-04-22 08:00AM
Dec-22-21 08:00AM
Dec-02-21 08:00AM
Dec-01-21 04:05PM
Nov-15-21 12:25PM
08:00AM
Nov-08-21 03:00PM
08:00AM
Nov-01-21 08:00AM
Oct-21-21 08:00AM
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.